|
dna recombination
|
GO:0006310 |
32 |
0.957
|
|
|
double strand break repair via synthesis dependent strand annealing
|
GO:0045003 |
6 |
0.944
|
|
|
dna repair
|
GO:0006281 |
54 |
0.937
|
|
|
dna metabolic process
|
GO:0006259 |
227 |
0.935
|
|
|
reciprocal meiotic recombination
|
GO:0007131 |
19 |
0.920
|
|
|
recombinational repair
|
GO:0000725 |
13 |
0.918
|
|
|
double strand break repair via homologous recombination
|
GO:0000724 |
13 |
0.864
|
|
|
dna geometric change
|
GO:0032392 |
16 |
0.821
|
|
|
double strand break repair
|
GO:0006302 |
26 |
0.743
|
|
|
meiotic cell cycle
|
GO:0051321 |
171 |
0.707
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
223 |
0.694
|
|
|
dna duplex unwinding
|
GO:0032508 |
16 |
0.689
|
|
|
dna synthesis involved in dna repair
|
GO:0000731 |
5 |
0.652
|
|
|
dna double strand break processing
|
GO:0000729 |
3 |
0.648
|
|
|
meiotic cell cycle process
|
GO:1903046 |
132 |
0.638
|
|
|
translesion synthesis
|
GO:0019985 |
2 |
0.555
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
33 |
0.517
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
59 |
0.509
|
|
|
regulation of dna recombination
|
GO:0000018 |
4 |
0.503
|
|
|
nuclear division
|
GO:0000280 |
332 |
0.498
|
|
|
female meiotic division
|
GO:0007143 |
70 |
0.489
|
|
|
developmental growth
|
GO:0048589 |
280 |
0.472
|
|
|
growth
|
GO:0040007 |
359 |
0.459
|
|
|
postreplication repair
|
GO:0006301 |
2 |
0.415
|
|
|
mitotic g2 dna damage checkpoint
|
GO:0007095 |
69 |
0.405
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
103 |
0.347
|
|
|
meiosis i
|
GO:0007127 |
59 |
0.324
|
|
|
nucleotide excision repair
|
GO:0006289 |
8 |
0.320
|
|
|
double strand break repair via nonhomologous end joining
|
GO:0006303 |
5 |
0.309
|
|
|
dna damage checkpoint
|
GO:0000077 |
78 |
0.297
|
|
|
dna conformation change
|
GO:0071103 |
105 |
0.293
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
74 |
0.292
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
58 |
0.291
|
|
|
response to light stimulus
|
GO:0009416 |
124 |
0.291
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
265 |
0.259
|
Human |
|
mitotic cell cycle phase transition
|
GO:0044772 |
138 |
0.259
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
75 |
0.257
|
|
|
regulation of developmental growth
|
GO:0048638 |
174 |
0.234
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
69 |
0.233
|
|
|
cell division
|
GO:0051301 |
248 |
0.230
|
|
|
non recombinational repair
|
GO:0000726 |
7 |
0.220
|
|
|
male gamete generation
|
GO:0048232 |
201 |
0.219
|
|
|
nucleotide metabolic process
|
GO:0009117 |
161 |
0.217
|
|
|
negative regulation of rna biosynthetic process
|
GO:1902679 |
240 |
0.211
|
Human |
|
chromosome organization
|
GO:0051276 |
360 |
0.172
|
|
|
chromosome separation
|
GO:0051304 |
42 |
0.171
|
Human |
|
response to abiotic stimulus
|
GO:0009628 |
341 |
0.165
|
|
|
meiotic nuclear division
|
GO:0007126 |
151 |
0.163
|
|
|
reciprocal dna recombination
|
GO:0035825 |
19 |
0.159
|
|
|
telomere maintenance via recombination
|
GO:0000722 |
1 |
0.152
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
108 |
0.152
|
|
|
mitotic g2 m transition checkpoint
|
GO:0044818 |
70 |
0.151
|
|
|
regulation of cell cycle
|
GO:0051726 |
291 |
0.135
|
|
|
regulation of cell cycle process
|
GO:0010564 |
181 |
0.135
|
|
|
response to alkaloid
|
GO:0043279 |
26 |
0.134
|
|
|
atp metabolic process
|
GO:0046034 |
49 |
0.133
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
109 |
0.132
|
|
|
multicellular organism growth
|
GO:0035264 |
46 |
0.131
|
|
|
chromatin organization
|
GO:0006325 |
207 |
0.125
|
|
|
gene silencing
|
GO:0016458 |
138 |
0.123
|
|
|
aging
|
GO:0007568 |
143 |
0.123
|
Worm |
|
carbohydrate derivative metabolic process
|
GO:1901135 |
217 |
0.119
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
109 |
0.115
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
51 |
0.114
|
|
|
regulation of cell death
|
GO:0010941 |
173 |
0.111
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
146 |
0.109
|
|
|
intracellular signal transduction
|
GO:0035556 |
300 |
0.108
|
|
|
organelle fission
|
GO:0048285 |
340 |
0.108
|
|
|
nucleobase containing compound catabolic process
|
GO:0034655 |
165 |
0.101
|
|
|
vesicle mediated transport
|
GO:0016192 |
381 |
0.100
|
|
|
regulation of nuclear division
|
GO:0051783 |
58 |
0.100
|
|
|
negative regulation of developmental process
|
GO:0051093 |
201 |
0.097
|
|
|
negative regulation of developmental growth
|
GO:0048640 |
64 |
0.093
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
127 |
0.091
|
|
|
regulation of intracellular signal transduction
|
GO:1902531 |
236 |
0.090
|
|
|
cellular response to radiation
|
GO:0071478 |
52 |
0.089
|
|
|
chromatin modification
|
GO:0016568 |
147 |
0.087
|
|
|
negative regulation of macromolecule biosynthetic process
|
GO:0010558 |
270 |
0.083
|
Human |
|
eye morphogenesis
|
GO:0048592 |
260 |
0.082
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
52 |
0.080
|
|
|
chromosome segregation
|
GO:0007059 |
157 |
0.080
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
130 |
0.080
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
11 |
0.079
|
|
|
death
|
GO:0016265 |
284 |
0.078
|
|
|
atp catabolic process
|
GO:0006200 |
38 |
0.078
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
108 |
0.076
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
108 |
0.074
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
34 |
0.072
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
88 |
0.072
|
|
|
regulation of meiosis
|
GO:0040020 |
3 |
0.072
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
119 |
0.071
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
116 |
0.071
|
|
|
homeostatic process
|
GO:0042592 |
199 |
0.069
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
119 |
0.068
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
318 |
0.067
|
|
|
negative regulation of nucleobase containing compound metabolic process
|
GO:0045934 |
261 |
0.067
|
Human |
|
endocytosis
|
GO:0006897 |
310 |
0.067
|
|
|
single organism catabolic process
|
GO:0044712 |
228 |
0.066
|
|
|
compound eye development
|
GO:0048749 |
307 |
0.065
|
|
|
cell proliferation
|
GO:0008283 |
299 |
0.064
|
|
|
organic substance catabolic process
|
GO:1901575 |
308 |
0.064
|
|
|
rna splicing
|
GO:0008380 |
83 |
0.062
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
103 |
0.062
|
|
|
dna biosynthetic process
|
GO:0071897 |
24 |
0.061
|
|
|
positive regulation of developmental process
|
GO:0051094 |
143 |
0.060
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
130 |
0.059
|
|
|
negative regulation of growth
|
GO:0045926 |
84 |
0.059
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
89 |
0.058
|
|
|
nucleotide catabolic process
|
GO:0009166 |
109 |
0.057
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
267 |
0.057
|
Human |
|
apoptotic process
|
GO:0006915 |
159 |
0.057
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
128 |
0.055
|
|
|
response to oxidative stress
|
GO:0006979 |
86 |
0.054
|
|
|
heterocycle catabolic process
|
GO:0046700 |
166 |
0.054
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
127 |
0.053
|
|
|
response to uv
|
GO:0009411 |
24 |
0.053
|
|
|
regulation of organelle organization
|
GO:0033043 |
196 |
0.053
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
112 |
0.053
|
|
|
sex differentiation
|
GO:0007548 |
81 |
0.053
|
|
|
mitotic sister chromatid segregation
|
GO:0000070 |
87 |
0.052
|
|
|
eye development
|
GO:0001654 |
323 |
0.050
|
|
|
regulation of multicellular organism growth
|
GO:0040014 |
40 |
0.050
|
|
|
response to purine containing compound
|
GO:0014074 |
12 |
0.050
|
|
|
cellular catabolic process
|
GO:0044248 |
372 |
0.049
|
|
|
cell death
|
GO:0008219 |
279 |
0.049
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
3 |
0.049
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
145 |
0.047
|
|
|
dna replication
|
GO:0006260 |
48 |
0.046
|
Human |
|
cellular response to ionizing radiation
|
GO:0071479 |
15 |
0.046
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
145 |
0.045
|
|
|
response to organic substance
|
GO:0010033 |
284 |
0.044
|
|
|
negative regulation of rna metabolic process
|
GO:0051253 |
251 |
0.044
|
Human |
|
cellular response to gamma radiation
|
GO:0071480 |
10 |
0.044
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
97 |
0.044
|
|
|
negative regulation of response to stimulus
|
GO:0048585 |
258 |
0.044
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
39 |
0.044
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
118 |
0.042
|
|
|
regulation of double strand break repair
|
GO:2000779 |
3 |
0.042
|
|
|
telomere capping
|
GO:0016233 |
11 |
0.041
|
|
|
larval development
|
GO:0002164 |
104 |
0.041
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
260 |
0.040
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
152 |
0.040
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
50 |
0.040
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
78 |
0.040
|
|
|
multicellular organismal aging
|
GO:0010259 |
140 |
0.040
|
Worm |
|
response to organic cyclic compound
|
GO:0014070 |
89 |
0.040
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
112 |
0.040
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
382 |
0.040
|
Human |
|
spermatogenesis
|
GO:0007283 |
200 |
0.039
|
|
|
cellular response to chemical stimulus
|
GO:0070887 |
199 |
0.039
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
174 |
0.039
|
|
|
appendage morphogenesis
|
GO:0035107 |
397 |
0.039
|
|
|
dna dependent dna replication
|
GO:0006261 |
17 |
0.038
|
|
|
negative regulation of cell cycle g2 m phase transition
|
GO:1902750 |
8 |
0.038
|
|
|
covalent chromatin modification
|
GO:0016569 |
106 |
0.037
|
|
|
regulation of programmed cell death
|
GO:0043067 |
152 |
0.037
|
|
|
negative regulation of cell communication
|
GO:0010648 |
223 |
0.037
|
|
|
immune response
|
GO:0006955 |
246 |
0.036
|
|
|
programmed cell death
|
GO:0012501 |
257 |
0.036
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
109 |
0.035
|
|
|
regulation of response to stress
|
GO:0080134 |
200 |
0.035
|
|
|
positive regulation of phosphorus metabolic process
|
GO:0010562 |
139 |
0.035
|
|
|
single organism biosynthetic process
|
GO:0044711 |
206 |
0.035
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
62 |
0.034
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
88 |
0.033
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
55 |
0.033
|
|
|
response to ionizing radiation
|
GO:0010212 |
32 |
0.033
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
165 |
0.032
|
|
|
nucleoside catabolic process
|
GO:0009164 |
112 |
0.032
|
|
|
cellular protein modification process
|
GO:0006464 |
438 |
0.032
|
|
|
regulation of cell division
|
GO:0051302 |
72 |
0.031
|
|
|
organophosphate metabolic process
|
GO:0019637 |
195 |
0.031
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
112 |
0.031
|
|
|
germarium derived egg chamber formation
|
GO:0007293 |
101 |
0.031
|
|
|
mitotic nuclear division
|
GO:0007067 |
213 |
0.031
|
|
|
response to radiation
|
GO:0009314 |
155 |
0.030
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
119 |
0.030
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
93 |
0.030
|
|
|
cell cycle phase transition
|
GO:0044770 |
140 |
0.029
|
|
|
central nervous system development
|
GO:0007417 |
201 |
0.029
|
|
|
histone modification
|
GO:0016570 |
106 |
0.029
|
|
|
regulation of dna repair
|
GO:0006282 |
5 |
0.029
|
|
|
post embryonic appendage morphogenesis
|
GO:0035120 |
385 |
0.029
|
|
|
telomere organization
|
GO:0032200 |
21 |
0.028
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
120 |
0.028
|
|
|
dorsal ventral axis specification
|
GO:0009950 |
66 |
0.027
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
145 |
0.027
|
|
|
brain development
|
GO:0007420 |
120 |
0.027
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
109 |
0.027
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
26 |
0.027
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
38 |
0.027
|
|
|
regulation of phosphate metabolic process
|
GO:0019220 |
210 |
0.027
|
|
|
regionalization
|
GO:0003002 |
416 |
0.026
|
|
|
positive regulation of molecular function
|
GO:0044093 |
136 |
0.026
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
136 |
0.026
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
89 |
0.026
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
168 |
0.025
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
162 |
0.025
|
|
|
regulation of cell size
|
GO:0008361 |
63 |
0.025
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
47 |
0.025
|
|
|
chromatin silencing
|
GO:0006342 |
76 |
0.025
|
|
|
positive regulation of multicellular organismal process
|
GO:0051240 |
143 |
0.025
|
|
|
response to organonitrogen compound
|
GO:0010243 |
75 |
0.025
|
|
|
negative regulation of nucleic acid templated transcription
|
GO:1903507 |
240 |
0.025
|
Human |
|
glycosyl compound catabolic process
|
GO:1901658 |
112 |
0.024
|
|
|
imaginal disc derived appendage development
|
GO:0048737 |
399 |
0.024
|
|
|
imaginal disc derived wing morphogenesis
|
GO:0007476 |
337 |
0.024
|
|
|
reproductive structure development
|
GO:0048608 |
74 |
0.023
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
50 |
0.023
|
|
|
regulation of growth
|
GO:0040008 |
233 |
0.023
|
|
|
single organism intracellular transport
|
GO:1902582 |
207 |
0.022
|
|
|
negative regulation of signal transduction
|
GO:0009968 |
206 |
0.022
|
|
|
immune system process
|
GO:0002376 |
347 |
0.022
|
|
|
cell aging
|
GO:0007569 |
2 |
0.022
|
|
|
dna integrity checkpoint
|
GO:0031570 |
81 |
0.022
|
|
|
centrosome duplication
|
GO:0051298 |
121 |
0.021
|
|
|
positive regulation of cell death
|
GO:0010942 |
69 |
0.021
|
|
|
regulation of phosphorus metabolic process
|
GO:0051174 |
210 |
0.021
|
|
|
protein complex assembly
|
GO:0006461 |
200 |
0.021
|
|
|
response to nitrogen compound
|
GO:1901698 |
90 |
0.021
|
|
|
protein modification process
|
GO:0036211 |
438 |
0.021
|
|
|
response to gamma radiation
|
GO:0010332 |
17 |
0.019
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
38 |
0.019
|
|
|
ion transport
|
GO:0006811 |
145 |
0.019
|
|
|
dendrite development
|
GO:0016358 |
204 |
0.019
|
|
|
jnk cascade
|
GO:0007254 |
50 |
0.019
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
50 |
0.019
|
|
|
organophosphate catabolic process
|
GO:0046434 |
112 |
0.018
|
|
|
cellular response to organic substance
|
GO:0071310 |
132 |
0.018
|
|
|
positive regulation of catalytic activity
|
GO:0043085 |
118 |
0.018
|
|
|
macromolecular complex assembly
|
GO:0065003 |
256 |
0.018
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
109 |
0.018
|
|
|
negative regulation of signaling
|
GO:0023057 |
219 |
0.018
|
|
|
response to external biotic stimulus
|
GO:0043207 |
293 |
0.018
|
|
|
nuclear transport
|
GO:0051169 |
72 |
0.017
|
|
|
immune response activating signal transduction
|
GO:0002757 |
2 |
0.017
|
|
|
gtp catabolic process
|
GO:0006184 |
72 |
0.017
|
|
|
germarium derived oocyte fate determination
|
GO:0007294 |
26 |
0.017
|
|
|
compound eye morphogenesis
|
GO:0001745 |
249 |
0.017
|
|
|
regulation of cell proliferation
|
GO:0042127 |
163 |
0.016
|
|
|
centrosome cycle
|
GO:0007098 |
137 |
0.016
|
|
|
proteolysis
|
GO:0006508 |
192 |
0.016
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
112 |
0.016
|
|
|
cell cycle checkpoint
|
GO:0000075 |
95 |
0.016
|
|
|
sister chromatid segregation
|
GO:0000819 |
92 |
0.016
|
|
|
wing disc morphogenesis
|
GO:0007472 |
344 |
0.016
|
|
|
macromolecule catabolic process
|
GO:0009057 |
161 |
0.016
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
97 |
0.015
|
|
|
regulation of apoptotic process
|
GO:0042981 |
130 |
0.015
|
|
|
response to biotic stimulus
|
GO:0009607 |
294 |
0.015
|
|
|
muscle structure development
|
GO:0061061 |
224 |
0.015
|
|
|
locomotory behavior
|
GO:0007626 |
176 |
0.015
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
127 |
0.015
|
|
|
single organism membrane organization
|
GO:0044802 |
93 |
0.014
|
|
|
positive regulation of immune system process
|
GO:0002684 |
68 |
0.014
|
|
|
negative regulation of transcription dna templated
|
GO:0045892 |
237 |
0.014
|
Human |
|
alternative mrna splicing via spliceosome
|
GO:0000380 |
60 |
0.014
|
|
|
aggressive behavior
|
GO:0002118 |
63 |
0.014
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
143 |
0.014
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
110 |
0.014
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
3 |
0.013
|
|
|
sensory perception of pain
|
GO:0019233 |
4 |
0.013
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
153 |
0.013
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
39 |
0.013
|
|
|
protein complex biogenesis
|
GO:0070271 |
201 |
0.013
|
|
|
oocyte dorsal ventral axis specification
|
GO:0007310 |
34 |
0.013
|
|
|
regulation of rna splicing
|
GO:0043484 |
69 |
0.013
|
|
|
nucleoside metabolic process
|
GO:0009116 |
127 |
0.013
|
|
|
negative regulation of biosynthetic process
|
GO:0009890 |
277 |
0.013
|
Human |
|
protein localization
|
GO:0008104 |
284 |
0.013
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
48 |
0.013
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
108 |
0.013
|
|
|
mushroom body development
|
GO:0016319 |
70 |
0.013
|
|
|
defense response
|
GO:0006952 |
300 |
0.012
|
|
|
establishment of tissue polarity
|
GO:0007164 |
87 |
0.012
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
127 |
0.012
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
190 |
0.012
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.012
|
|
|
establishment of ommatidial planar polarity
|
GO:0042067 |
49 |
0.011
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
155 |
0.011
|
|
|
ras protein signal transduction
|
GO:0007265 |
88 |
0.011
|
|
|
positive regulation of growth
|
GO:0045927 |
75 |
0.011
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
62 |
0.011
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
55 |
0.011
|
|
|
small molecule metabolic process
|
GO:0044281 |
305 |
0.011
|
|
|
regulation of cell differentiation
|
GO:0045595 |
302 |
0.011
|
|
|
dna amplification
|
GO:0006277 |
11 |
0.011
|
|
|
positive regulation of gene expression
|
GO:0010628 |
290 |
0.011
|
|
|
regulation of stress activated protein kinase signaling cascade
|
GO:0070302 |
42 |
0.011
|
|
|
intra s dna damage checkpoint
|
GO:0031573 |
2 |
0.011
|
|
|
dorsal ventral pattern formation
|
GO:0009953 |
133 |
0.011
|
|
|
gonad development
|
GO:0008406 |
50 |
0.011
|
|
|
positive regulation of cellular biosynthetic process
|
GO:0031328 |
316 |
0.011
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
414 |
0.011
|
|
|
positive regulation of signaling
|
GO:0023056 |
243 |
0.010
|
|
|
forebrain development
|
GO:0030900 |
2 |
0.010
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
50 |
0.010
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
65 |
0.010
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
92 |
0.010
|
|